jo_k_er_man
09-23-2005, 10:49 PM
Tokyo, Japan: Cannabinoids may play a role in the treatment of various inflammatory diseases, including rheumatoid arthritis and allergic asthma, according to a review published in the September issue of the Journal of Neuroimmunology.
A research team from Tokyo's National Institute of Neuroscience, Department of Immunology, wrote, "Current studies suggest that cannabinoids may prove to be useful alternatives ... in treating a variety of human inflammatory disorders" because they modulate both the function and secretion of cytokines (regulatory proteins that are released by immune cells and are responsible for an immune response).
In particular, authors note that cannabinoids may play a role in the treatment of Multiple Sclerosis, rheumatoid arthritis, diabetes, and allergic asthma.
A 2003 study (javascript:ol('index.cfm?Group_ID%3d5719');) published in the journal Brain found that "cannabis may ... slow down the neurodegenerative processes that ultimately lead to chronic disability in multiple sclerosis and probably other diseases."
[i]For more information, please contact Paul Armentano (http://by102fd.bay102.hotmail.msn.com/cgi-bin/compose?mailto=1&msg=AB535882-B0AC-4130-9A93-1EED65CA9F0B&start=0&len=14940&src=&type=x&to=paul@norml.org&cc=&bcc=&subject=&body=&curmbox=00000000-0000-0000-0000-000000000001&a=5b448176132f8a5adceed7f33d57e78b72134b71d013c2c0 86a9e9030c94b39e), NORML Senior Policy Analyst, at (202) 483-5500. Full text of the study, "Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases?" is available in the September issue of the Journal of Neuroimmunology.
A research team from Tokyo's National Institute of Neuroscience, Department of Immunology, wrote, "Current studies suggest that cannabinoids may prove to be useful alternatives ... in treating a variety of human inflammatory disorders" because they modulate both the function and secretion of cytokines (regulatory proteins that are released by immune cells and are responsible for an immune response).
In particular, authors note that cannabinoids may play a role in the treatment of Multiple Sclerosis, rheumatoid arthritis, diabetes, and allergic asthma.
A 2003 study (javascript:ol('index.cfm?Group_ID%3d5719');) published in the journal Brain found that "cannabis may ... slow down the neurodegenerative processes that ultimately lead to chronic disability in multiple sclerosis and probably other diseases."
[i]For more information, please contact Paul Armentano (http://by102fd.bay102.hotmail.msn.com/cgi-bin/compose?mailto=1&msg=AB535882-B0AC-4130-9A93-1EED65CA9F0B&start=0&len=14940&src=&type=x&to=paul@norml.org&cc=&bcc=&subject=&body=&curmbox=00000000-0000-0000-0000-000000000001&a=5b448176132f8a5adceed7f33d57e78b72134b71d013c2c0 86a9e9030c94b39e), NORML Senior Policy Analyst, at (202) 483-5500. Full text of the study, "Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases?" is available in the September issue of the Journal of Neuroimmunology.